[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Special Feature
July 2001

Radiological Case of the Month

Arch Pediatr Adolesc Med. 2001;155(7):848. doi:10.1001/archpedi.155.7.847
Denouement and Discussion: Cerebral Air Embolism in Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease)

Figure 1. Pulmonary arteriovenous malformation.

Figure 2. Pulmonary hemorrhage.

Figure 3. Initial computed tomography of the brain demonstrating diffuse pneumocephaly with edema and mass effect without hemorrhage.

Osler-Weber-Rendu disease (OWR), or hereditary hemorrhagic telangiectasia, is an autosomal dominant disorder involving vascular structures throughout the body. The incidence of OWR is estimated at 1 to 2 per 100 000.1 The classic triad consists of telangiectasias, epistaxis, and previous familial history. Because of variable penetrance, a family history of OWR may be absent. This patient's mother and grandfather had a history of recurrent gastrointestinal bleeding, and the mother required frequent blood transfusions. The underlying pathologic abnormality of OWR is a combination of insufficient smooth muscle contractile elements, endothelial cell junction defects, and perivascular connective tissue weakness.1 These defects give rise to telangiectasias, arteriovenous malformations (AVMs), and aneurysms. Two gene defects have been linked to OWR. The defect involves the endoglin gene located on chromosome 9, which is often associated with pulmonary and cerebral AVMs.2

A defect located on the ALK1 gene on chromosome 12 has also been reported.3 Epistaxis is often an initial presenting manifestation. Cutaneous telangiectasias may not manifest until the second or third decade of life. Aneurysms and AVMs may affect multiple organs. Lesions of the gastrointestinal tract manifest as painless bleeding.1 Fibrovascular infiltration of the liver can cause hepatomegaly, and left-to-right shunting through fistulas may cause high-output congestive heart failure.4

This patient's prior hemoptysis was associated with a pulmonary AVM; these are found in 5% to 15% of patients affected with OWR.4 Most often these fistulas remain stable or gradually expand over decades.1 Treatment for pulmonary AVMs or fistulas is surgical excision, embolization, or ligation, and is reserved for those fistulas or AVMs that are expanding or symptomatic. A cerebral air embolism can occur from a pulmonary AVM,5 leading rapidly to progressive cerebral edema, uncal herniation, and death. Other more common neurologic complications of OWR-associated AVMs include septic microemboli, producing an abscess or meningitis, and vascular malformations of the brain and spinal cord.4 Patients may develop headaches or transient ischemic attacks.

Although patients with OWR can have repeated episodes of hemorrhage, the lifespan is neither inevitably reduced nor is quality of life impaired.1 Treatment is supportive, including iron therapy for chronic anemia. Frequent transfusions, surgical resection, embolization, or irradiation may be necessary for repeated bleeding or life-threatening AVMs. The use of hormonal therapy (mostly oral estrogens) has been reported for severe cases of recurrent epistaxis and for recurrent gastrointestinal bleeding.6,7

Back to top
Article Information

Accepted for publication November 3, 1999.

Reprints: Toni M. Petrillo, MD, Children's Healthcare of Atlanta at Egleston, Division of Pediatric Critical Care, 1405 Clifton Rd NE, Atlanta, GA 30322 (e-mail: toni.petrillo@CHOA.org).

References
1.
Perry  WH Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med. 1987;82989- 997Article
2.
Shovlin  CL Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet. 1997;6168- 79Article
3.
Johnson  DWBerg  JNBaldwin  MA  et al.  Mutations in activin receptor-like kinase gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet. 1996;13189- 195Article
4.
Guttmacher  AEMarchuk  DAWhite  RI  Jr Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995;333918- 924Article
5.
Stanley  IMHunter  KR Neurological manifestations of hereditary hemorrhagic teleangiectasia. BMJ. 1970;3688Article
6.
Custem  EV Estrogen-progesterone treatment of Osler-Weber-Rendu disease. J Clin Gatroenterol. 1988;10676- 679Article
7.
Custem  EV Treatment of bleeding gastrointestinal vascular malformations with estrogen-progesterone. Lancet. 1990;335953- 955Article
×